Clinical Highlights From the American Diabetes Association's Scientific Sessions episode artwork

EPISODE · Jul 26, 2024 · 18 MIN

Clinical Highlights From the American Diabetes Association's Scientific Sessions

from JAMA Medical News

Endocrinologist Robert Gabbay, MD, PhD, the ADA's chief scientific and medical officer, speaks with JAMA Medical News about clinical research highlights from the annual meeting, including some of the latest data on blockbuster weight loss medications, "game-changing" diabetes technologies, and a new use for a familiar drug. Related Content: New Data on GLP-1s, Diabetic Retinopathy, and CGMs—Highlights From the ADA's Scientific Sessions

NOW PLAYING

Clinical Highlights From the American Diabetes Association's Scientific Sessions

0:00 18:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of JAMA Medical News?

This episode is 18 minutes long.

When was this JAMA Medical News episode published?

This episode was published on July 26, 2024.

What is this episode about?

Endocrinologist Robert Gabbay, MD, PhD, the ADA's chief scientific and medical officer, speaks with JAMA Medical News about clinical research highlights from the annual meeting, including some of the latest data on blockbuster weight loss...

Can I download this JAMA Medical News episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!